Stay updated on Erythromycin for APC Gene Stop Codon in FAP Clinical Trial
Sign up to get notified when there's something new on the Erythromycin for APC Gene Stop Codon in FAP Clinical Trial page.

Latest updates to the Erythromycin for APC Gene Stop Codon in FAP Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed information about colorectal cancer and the introduction of a new study protocol for erythromycin treatment in patients with Familial Adenomatous Polyposis (FAP).SummaryDifference33%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check74 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check88 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check95 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to Erythromycin for APC Gene Stop Codon in FAP Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Erythromycin for APC Gene Stop Codon in FAP Clinical Trial page.